Progyny CFO sells 459 shares of stock in automatic trading plan
Progyny, Inc. reported an insider stock transaction by its chief financial officer, Mark S. Livingston.
Rhea-AI Filing Summary
Progyny, Inc. reported an insider stock transaction by its chief financial officer, Mark S. Livingston. On December 11, 2025, he sold 459 shares of Progyny common stock at $25.5 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan that was entered into on August 15, 2025. Following this transaction, he directly owns 46,983 shares of Progyny common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 459 | $25.50 | $12K |
Footnotes (1)
- F1. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on August 15, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Progyny (PGNY) disclose in this filing?
The filing discloses that Progyny's chief financial officer, Mark S. Livingston, sold 459 shares of Progyny common stock on December 11, 2025.
What is Mark S. Livingston's role at Progyny (PGNY)?
Mark S. Livingston is identified as an officer of Progyny, serving as the company's Chief Financial Officer.
Is this Progyny (PGNY) insider filing for one reporting person or multiple?
The filing is indicated as a Form filed by one reporting person, covering only Mark S. Livingston.
AI-generated analysis. How Rhea-AI works. Not financial advice.